Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy

Major Program
Supportive Care and Symptom Management
Research Group
Community Oncology and Prevention Trials
Sponsor
University of North Carolina, Chapel Hill
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT01900418
For post-menopausal women diagnosed with hormone-receptor positive breast cancer tumors, aromatase inhibitors (AIs) are the standard adjuvant hormone treatment to prolong disease-free survival and time-to-recurrence. Unfortunately, joint pain/stiffness/achiness (arthralgia) is a common side-effect of AIs. This "proof-of-concept" study explores how an evidence-based physical activity (PA) program- the Arthritis Foundation's Walk with Ease (WWE) program- can be adapted for breast cancer survivors on AI therapy to: 1) Help them maintain or achieve recommended levels of PA, 2) reduce their joint pain/stiffness/achiness, and 3) thereby enable them to remain on AI therapy as prescribed.
Intervention
Walk with Ease
Condition
Joint Pain, Breast Cancer
Investigators
Leigh F Callahan, PhD

See list of participating sites